This article appears in the following Europace issue: Spotlight Issue: Cardiac Imaging in EP and CRT [View the issue table of contents]
IMAGING IN CRT
Magnetic resonance imaging and computed tomography in assessing cardiac veins and scar tissue
Department of Cardiology, Leiden University Medical Center, Postbox 9600, 2300 RC Leiden, The Netherlands
* Corresponding author. Tel: +31 71 5262020; fax: +31 071 5266809. E-mail address: N.R.L.van_de_Veire{at}lumc.nl
| Abstract |
|---|
|
|
|---|
The success of cardiac resynchronization therapy is influenced by several issues including cardiac venous anatomy and myocardial scar tissue. This article discusses non-invasive imaging modalities that could contribute significantly to the selection process of cardiac resynchronization therapy (CRT) candidates: multi-slice computed tomography to depict the coronary sinus tributaries and magnetic resonance imaging to identify scar tissue.
Key Words: Cardiac resynchronization therapy, Viability, Coronary sinus, Multi-slice computed tomography, Magnetic resonance imaging
| Introduction |
|---|
|
|
|---|
In order to improve the response rate, several issues need to be addressed during the selection process of cardiac resynchronization therapy (CRT) candidates.1
| Importance of non-invasive evaluation of cardiac venous anatomy with multi-slice computed tomography in CRT candidates |
|---|
|
|
|---|
The most challenging part of a CRT device implantation through an endovascular approach is positioning the left ventricular (LV) lead in a branch of the coronary sinus. In most textbooks on human anatomy, emphasis is on coronary arteries and cardiac veins are discussed superficially. A systematic approach to cardiac venous anatomy has been published by von Lüdinghausen.3
Obviously, pre-procedural knowledge of the cardiac venous anatomy of an individual patient could contribute significantly to the success of the implantation. Until recently, invasive venography was the only method to depict the cardiac veins in vivo. Two invasive techniques are available. Direct venography is based on direct manual injection of contrast into the guiding catheter. Most cardiologists prefer an alternative invasive technique: occlusive venography. An occlusion catheter is advanced through the guiding catheter, and a balloon is inflated with 1–1.5 ml air immediately beyond the distal tip of the guiding catheter. Occlusive venography causes more dissections, uses more contrast, has a longer procedure time but has more success to identify the anatomy.4
Similar to the post-mortem series, variations in cardiac venous anatomy have been reported with invasive venography.5
Owing to its invasive nature, venography is generally not used in advance but during the CRT implantation procedure itself. A prerequisite for a technique that provides information on venous anatomy during the selection process rather than during the CRT implantation should be its non-invasive nature. Some authors reported on the feasibility of electron beam computed tomography (EBCT) to depict the cardiac veins non-invasively.6
–8
Meanwhile, EBCT has been replaced by new technology to assess obstructive coronary artery disease: multi-slice CT (MSCT). This promising non-invasive technique provides three-dimensional information on cardiac structure, including cardiac veins (Figure 1).
|
After an initial case report, several authors published preliminary data using 16-slice MSCT.9
|
If suitable cardiac veins are absent, this might hamper transvenous LV lead positioning and a surgical approach should be preferred. If suitable veins are present, then it is also important to position the LV lead in the area of latest mechanical activation. In a preliminary study, 21 consecutive heart failure patients scheduled for CRT implantation were prospectively enrolled to undergo 64-slice CT to visualize the venous system, invasive venography during device implantation and tri-plane tissue synchronization imaging (TSI) before and after implantation (Figure 3).15
|
| Importance of non-invasive evaluation of scar tissue with magnetic resonance imaging in CRT candidates |
|---|
|
|
|---|
Another important reason for non-response to CRT (in patients with ischaemic cardiomyopathy) may be the presence of scar tissue in the region where the LV pacing lead is positioned. Pacing in non-viable or scarred myocardium may result in less effective or even ineffective pacing and as a result failure of LV resynchronization and no response to CRT. One imaging modality that permits non-invasive assessment of viability is nuclear perfusion imaging.16
120 ms than in patients with a QRS < 120 ms (29 vs. 7%; P < 0.01). Ypenburg et al. evaluated the presence of scar tissue with gated SPECT using 99mTc-tetrofosmin before CRT implantation. Patients without scar tissue in the LV pacing target region significantly improved in functional class, quality of life, 6 min walk test, LV volumes and ejection fraction, whereas no improvement was observed in patients with scar tissue.18
Another non-invasive imaging modality to evaluate myocardial scar is cardiac magnetic resonance imaging (MRI). Contrast-enhanced MRI allows precise determination of the spatial and transmural extent of scar tissue. Bleeker et al.19
studied 40 coronary artery disease patients with MRI before undergoing CRT. One-third of the patients had a transmural posterolateral scar tissue (Figure 4), well in line with nuclear imaging observations.17
,19
In contrast to patients without posterolateral scar tissue, these patients showed a low response rate and did not show improvement in clinical or echocardiographic parameters.19
In addition, LV dyssynchrony remained unchanged after CRT implantation in the presence of scar tissue. White et al.20
evaluated the ability of delayed enhancement MRI to predict clinical response to CRT. They found that the percentage of total scar was significantly higher in the non-response vs. the response group. Some authors report greater reverse remodelling and improvement in LV ejection fraction after CRT in non-ischaemic patients than in ischaemic patients.21
This suggests that not only the location but also the size of infarcted myocardium—total scar burden—is important for response to CRT. Ypenburg et al.22
studied 34 patients with an ischaemic cardiomyopathy scheduled to undergo CRT. Contrast-enhanced MRI was used to determine total scar burden, using a 17-segment model with a 5-point hyperenhancement scale. There was a significant correlation between total scar burden at baseline and change in LV end-systolic volume after 6 months of CRT. Patients not responding to CRT had significantly more scar tissue than responders. A scar burden >1.20 resulted in complete functional non-response. Cardiac MRI could potentially provide information on both myocardial scar tissue and cardiac venous anatomy. In a recent publication, Nezafat et al.23
report on the technical aspects of imaging the cardiac veins with MRI. Further clinical validation is needed before integrating MRI cardiac venography into clinical practice.
|
| Conclusion |
|---|
|
|
|---|
Non-invasive imaging modalities can contribute significantly to the selection process of CRT candidates by providing answers to three crucial questions determining LV lead position. What is the area of latest mechanical activation? Does the target region for LV pacing contain viable myocardium? Is their a suitable tributary of the coronary sinus draining that area, allowing a transvenous approach? State-of-the-art non-invasive imaging modalities such as advanced echocardiography, MSCT, nuclear imaging, and cardiac MRI can provide this information.
Conflict of interest: J.J.B. received grants from Medtronic, Boston Scientific, BMS medical imaging, St Jude Medical & GE Healthcare. M.J.S. received grants from Biotronik, Medtronic & Boston Scientific.
| References |
|---|
|
|
|---|
[1] Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S, et al. Cardiac resynchronization therapy: part 1—issues before device implantation. J Am Coll Cardiol (2005) 46:2153–67.
[2] Bleeker GB, Yu C-M, Nihoyannopoulos P, De Sutter J, Van de Veire N, Holman ER, et al. Optimal use of echocardiography in cardiac resynchronisation therapy. Heart (2007) 93:1339–50.
[3] von Lüdinghausen M. The venous drainage of the human myocardium. Adv Anat Embryol Cell Biol (2003) 168:1–107.
[4] De Martino G, Messano L, Santamaria M, Parisi O, Dello Russo A, Pelargonio G, et al. A randomized evaluation of different approaches to coronary sinus venography during biventricular pacemaker implants. Europace (2005) 7:73–6.
[5] Meisel E, Pfeiffer D, Engelmann L, Tebbenjohanns J, Schubert B, Hahn S, et al. Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation (2001) 104:442–7.
[6] Schaffler GJ, Groell R, Peichel KH, Rienmüller R. Imaging the coronary venous drainage system using electron-beam CT. Surg Radiol Anat (2000) 22:35–9.[CrossRef][Web of Science][Medline]
[7] Gerber TC, Sheedy PF, Bell MR, Hayes DL, Rumberger JA, Behrenbeck T, et al. Evaluation of the coronary venous system using electron beam computed tomography. Int J Cardiovasc Imaging (2001) 17:65–75.[CrossRef][Medline]
[8] Mao S, Shinbane JS, Girsky MJ, Child J, Carson S, Oudiz RJ, et al. Coronary venous imaging with electron beam computed tomographic angiography: three-dimensional mapping and relationship with coronary arteries. Am Heart J (2005) 150:315–22.[CrossRef][Web of Science][Medline]
[9] Tada H, Naito S, Koyama K, Taniguchi K. Three-dimensional computed tomography of the coronary venous system. J Cardiovasc Electrophysiol (2003) 14:385.
[10] Abbara S, Cury RC, Nieman K, Reddy V, Moselewski F, Schmidt S, et al. Noninvasive evaluation of cardiac veins with 16-MDCT angiography. Am J Roentgenol (2005) 185:1001–6.
[11] Mühlenbruch G, Koos R, Wildberger JE, Günther R, Mahnken AH. Imaging of the cardiac venous system: comparison of MDCT and conventional angiography. Am J Roentgenol (2005) 185:1252–7.
[12] Jongbloed MRM, Lamb HJ, Bax JJ, Schuijf JD, de Roos A, van der Wall EE, et al. Noninvasive visualization of the cardiac venous system using multislice computed tomography. J Am Coll Cardiol (2005) 45:749–53.
[13] Van de Veire N, Schuijf JD, De Sutter J, Devos D, Bleeker GB, De Roos A, et al. Non-invasive visualisation of the cardiac venous system in coronary artery disease patients using 64-slice computed tomography. J Am Coll Cardiol (2006) 48:1832–8.
[14] Blendea D, Shah RV, Auricchio A, Nandigam V, Orencole M, Heist EK, et al. Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: a high-speed rotational venography study. Heart Rhythm (2007) 4:1163–4.[CrossRef][Web of Science][Medline]
[15] Van de Veire NR, Ajmone-Marsan N, Schuijf JD, Bleeker GB, Wijffels MCEF, van Erven L, et al. Non-invasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and non-invasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy. Am J Cardiol (2008) 101:1023–9.[CrossRef][Web of Science][Medline]
[16] Henneman MM, van der Wall EE, Ypenburg C, Bleeker GB, Van de Veire NR, Ajmone Marsan N, et al. Nuclear imaging in cardiac resynchronization therapy. J Nucl Med (2007) 48:2001–10.
[17] De Winter O, Van de Veire N, Van Heuverswijn F, Van Pottelberge G, Gillebert TC, De Sutter J. Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction. Eur J Heart Fail (2006) 8:275–7.[CrossRef][Web of Science][Medline]
[18] Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J (2007) 28:33–41.
[19] Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation (2006) 113:969–76.
[20] White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol (2006) 48:1953–60.
[21] Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA, Curtis AB. Ventricular reverse remodeling after 6-month outcomes in patients receiving CRT: analysis of the MIRACLE study. J Interv Card Electrophysiol (2005) 12:107–13.[CrossRef][Web of Science][Medline]
[22] Ypenburg C, Roes SD, Bleeker GB, Kaandorp TAM, de Roos A, Schalij MJ, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol (2007) 99:657–60.[CrossRef][Web of Science][Medline]
[23] Nezafat R, Han Y, Peters DC, Herzka DA, Wylie JV, Goddu B, et al. Coronary magnetic resonance vein imaging: imaging contrast, sequence, and timing. Magn Reson Med (2007) 58:1196–206.[CrossRef][Web of Science][Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Tournoux, R. C. Chan, R. Manzke, M. D. Hanschumacher, A. A. Chen-Tournoux, O. Gerard, J. Solis-Martin, E. K. Heist, P. Allain, V. Reddy, et al. Integrating functional and anatomical information to guide cardiac resynchronization therapy Eur J Heart Fail, January 1, 2010; 12(1): 52 - 57. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




